Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

Recruiting N/A Interventional Study
Neuropathic Pain Anxiety Disorder/Anxiety State Pain, Chronic Alcohol Use Disorder Psychoactive Substance Use Sleep Symptoms and Signs Addiction Nicotine
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
120 (estimated)
Sponsor
University Hospital, Caen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Head and neck cancers are a source of complications and after-effects related to the disease and treatment. These cancers and their treatment alter the quality of life of patients and generate pain with physical and psychological components. Chronic pain affects 36% of patients at 6 months and 30% after this period. These pains are responsible for the consumption of level II and III analgesics in …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with a first Head and neck cancer whose therapeutic sequence involves radiotherapy * Patient over 18 years of age * Having given written consent * patient not previously treated with radiotherapy * Life expectancy \> 3 months * World Health Organization (WHO) score \<…
Contacts

Maxime Humbert, MD

0231064640

humbert-m@chu-caen.fr

CONTACT

Emmanuel Babin, PHD

0231064640

babin-e@chu-caen.fr

CONTACT